Computerized relational database for monitoring clozapine therapy

Area of Science:

• Pharmacology
• Health Informatics
• Psychiatric Pharmacy Practice

Background:

• Clozapine requires rigorous patient monitoring, including regular white blood cell (WBC) counts, due to potential serious side effects.
• Managing these monitoring requirements presents a significant logistical challenge for healthcare facilities.
• Manufacturer guidelines necessitate specific data collection and reporting for clozapine therapy.

Purpose of the Study:

• To describe the implementation and benefits of a computerized relational database for managing clozapine patient monitoring.
• To assess the system's impact on workload, cost, and clinical monitoring efficiency.
• To demonstrate a practical solution for meeting clozapine manufacturer requirements in a state psychiatric hospital.

Main Methods:

• Development of a computerized relational database system by the pharmacy department.
• Utilizing the database to retrieve and organize patient data, including WBC counts, psychiatric test results, and financial information.
• Generating standardized and customized reports for the manufacturer, other providers, physicians, and hospital administration.

Main Results:

• The system minimized the additional workload associated with clozapine dispensing.
• Achieved cost savings of $234,441 compared to a closed distribution system.
• Facilitated comprehensive clinical monitoring, with pharmacists notifying physicians for 86 patients not meeting WBC-count criteria out of 168 recipients monitored.

Conclusions:

• A computerized relational database effectively manages the complexities of clozapine patient monitoring.
• Implementation led to significant cost reductions and improved operational efficiency.
• The system supports robust clinical oversight, ensuring patient safety and adherence to manufacturer guidelines.